1. Home
  2. ABUS vs NPK Comparison

ABUS vs NPK Comparison

Compare ABUS & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.26

Market Cap

884.7M

Sector

Health Care

ML Signal

HOLD

Logo National Presto Industries Inc.

NPK

National Presto Industries Inc.

HOLD

Current Price

$131.58

Market Cap

983.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
NPK
Founded
2005
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
884.7M
983.1M
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
ABUS
NPK
Price
$4.26
$131.58
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
2.3M
68.4K
Earning Date
01-01-0001
06-04-2026
Dividend Yield
N/A
0.75%
EPS Growth
13.64
N/A
EPS
N/A
0.99
Revenue
$6,171,000.00
$388,228,000.00
Revenue This Year
$125.30
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$133.90
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$77.63
52 Week High
$5.10
$149.86

Technical Indicators

Market Signals
Indicator
ABUS
NPK
Relative Strength Index (RSI) 43.48 49.02
Support Level $4.23 $103.97
Resistance Level $4.69 $137.78
Average True Range (ATR) 0.23 6.36
MACD -0.03 -0.57
Stochastic Oscillator 6.25 27.31

Price Performance

Historical Comparison
ABUS
NPK

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: